- Home
- RFIL vs MAIA Comparison
RFIL vs MAIA Comparison
Compare RFIL & MAIA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RFIL
- MAIA
- Stock Information
- Founded
- RFIL 1979
- MAIA 2018
- Country
- RFIL United States
- MAIA United States
- Employees
- RFIL N/A
- MAIA N/A
- Industry
- RFIL Electrical Products
- MAIA Biotechnology: Pharmaceutical Preparations
- Sector
- RFIL Technology
- MAIA Health Care
- Exchange
- RFIL Nasdaq
- MAIA Nasdaq
- Market Cap
- RFIL 39.9M
- MAIA 44.8M
- IPO Year
- RFIL N/A
- MAIA 2022
- Fundamental
- Price
- RFIL $3.82
- MAIA $1.55
- Analyst Decision
- RFIL Strong Buy
- MAIA
- Analyst Count
- RFIL 1
- MAIA 0
- Target Price
- RFIL $4.50
- MAIA N/A
- AVG Volume (30 Days)
- RFIL 38.1K
- MAIA 75.2K
- Earning Date
- RFIL 06-12-2025
- MAIA 05-13-2025
- Dividend Yield
- RFIL N/A
- MAIA N/A
- EPS Growth
- RFIL N/A
- MAIA N/A
- EPS
- RFIL N/A
- MAIA N/A
- Revenue
- RFIL $70,599,000.00
- MAIA N/A
- Revenue This Year
- RFIL $16.16
- MAIA N/A
- Revenue Next Year
- RFIL $5.75
- MAIA N/A
- P/E Ratio
- RFIL N/A
- MAIA N/A
- Revenue Growth
- RFIL 4.93
- MAIA N/A
- 52 Week Low
- RFIL $2.86
- MAIA $1.40
- 52 Week High
- RFIL $5.77
- MAIA $5.99
- Technical
- Relative Strength Index (RSI)
- RFIL 40.43
- MAIA 46.60
- Support Level
- RFIL $3.76
- MAIA $1.41
- Resistance Level
- RFIL $4.17
- MAIA $1.61
- Average True Range (ATR)
- RFIL 0.30
- MAIA 0.11
- MACD
- RFIL -0.05
- MAIA 0.01
- Stochastic Oscillator
- RFIL 28.48
- MAIA 62.50
About RFIL RF Industries Ltd.
RF Industries Ltd is engaged in the design, manufacture, and marketing of interconnect products and systems, including coaxial and specialty cables, fiber optic cables and connectors, and electrical and electronic specialty cables. The company operates through two segments: RF Connector and Cable Assembly, which consists of the Connector and Cable Assembly Division, and Custom Cabling Manufacturing and Assembly, which consists of its subsidiaries. The company has operations in the United States, Canada, Israel, and Mexico.
About MAIA MAIA Biotechnology Inc.
MAIA Biotechnology Inc is a clinical-stage biopharmaceutical company. The company develops targeted immunotherapies for cancer. The company is an immune-oncology company, focused on the development of first-in-class drugs with novel mechanisms of action that are intended to meaningfully improve and extend the lives of people with cancer. The company's program is THIO, a potential cancer telomere-targeting agent in clinical development for the treatment of telomerase-positive cancer cells.